Is Gilbert Syndrome a new risk factor for breast cancer?

Medical Hypotheses

Volumn 77, Issue 2, 2011, Pages 162-164

  Astolfi, Rafael Haddad ^a   Bugano, Diogo Diniz Gomes ^a   Francisco, Alice Aparecida Rodrigues Ferreira ^b   Souza, Marcelo Moreira Tavares de ^a   Ono Nita, Suzane Kioko ^a   Baracat, Edmund Chada ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Instituto Brasileiro de Controle do Cancer   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; ESTROGEN DERIVATIVE; GLUCURONOSYLTRANSFERASE 1A1;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; DISEASE ASSOCIATION; FAMILY HISTORY; GENETIC POLYMORPHISM; GENETICS; GILBERT DISEASE; HUMAN; HYPOTHESIS; PROTEIN DEGRADATION; RISK ASSESSMENT; THEORY;

BREAST NEOPLASMS; ESTROGENS; FEMALE; GILBERT DISEASE; GLUCURONOSYLTRANSFERASE; HUMANS; MODELS, BIOLOGICAL; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 79960640102     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.03.047     Document Type: Article

References (22)

1. Woodwart W.A., et al. Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival. J Clin Oncol 2003, 21(17):3244-3248.
2. Toniolo P.G., Levitz M., Zeleniuch-Jacquotte A., et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. Natl Cancer Inst 1995, 87:190-197.
3. Zeleniuch-Jacquotte A., Toniolo P., Levitz M., et al. Endogenous estrogens and risk of breast cancer by estrogen receptor status: a prospective study in postmenopausal women. Cancer Epidemiol Biomarkers Prev 1995, 4:857-860.
4. Beral V., Bull D. Breast câncer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast câncer and 108 411 women without breast cancer. Lancet 1997, 350(9084):1047. 13 p, 15 charts, 1 graph.
5. Lambe, et al. Transient increase in the risk of breast cancer after giving birth. N Engl J Med 1994, 331(1):5-9.
6. Gilbert A., Lereboullet P. La cholemie simple familiale. Sem Med 1901, 21:241-243.
7. Clemons M., Goss P. Estrogen and the Risk of Breast Cancer. N Engl J Med 2001, 344(4).
8. Liehr J.G. Is estradiol a genotoxic mutagenic carcinogen?. Endocr Rev 2000, 21:40-54.
9. Bosma P., Chowdhury J.R., Jansen P.H. Genetic inheritance of Gilbert's Syndrome. Lancet 1995, 346(8970):314-315.
10. Bosma P.J. Inherited disorders of bilirubin metabolism. J Hepatol 2003 Jan, 38(1):107-117.
11. Bosma P.J., Chowdhury J.R., Bakker C., Gantla S., de B.A., Oostra B.A., et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's Syndrome. N Engl J Med 1995, 333(18):1171-1175.
12. Beutler E., Gelbart T., Demina A. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?. Proc Natl Acad Sci USA 1998, 95(14):8170-8174.
13. Premawardhena A., Fisher C.A., Liu Y.T., Verma I.C., de S.S., Arambepola M., et al. The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): hematologic and evolutionary implications. Blood Cells Mol Dis 2003, 31(1):98-101.
14. Yager J.D. Endogenous estrogens as carcinogens through metabolic activation. J Natl Cancer Inst Monogr 2000, (27):67-73.
15. Li K.M., et al. Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3, 4-quinone in vitro and in female ACI rat mammary gland in vivo. Carcinogenesis 2004, 25(2):289-297.
16. Retha R., Newbold R.R. Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Res 2000, 60(2):235-237.
17. Clemons M., Goss P. Estrogen and the risk of breast cancer. N Engl J Med 2001, 344(4):276-285.
18. Shatalova E.G., Loginov V.I., Braga E.A., et al. Association of polymorphisms in SULT1A1 and UGT1A1 Genes with breast cancer risk and phenotypes in Russian women. Mol Biol (Mosk) 2006, 40(2):263-270.
19. Adegoke O.J., Shu X.O., Gao Y.T., et al. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 (UGT1A1) and risk of breast cancer. Breast Cancer Res Treat 2004, 85(3):239-245.
20. Shatalova E.G., Walther S.E., Favorova O.O., Rebbeck T.R., Blanchard R.L. Genetic polymorphisms in human SULT1A1 and UGT1A1 genes associate with breast tumor characteristics: a case-series study. Breast Cancer Res 2005, 7(6):R909-R921.
21. Sparks R., Ulrich C.M., Bigler J., et al. UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients. Breast Cancer Res 2004, 6(5):R488-R498.
22. Yamamoto K., et al. Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II. Biochim Biophys Acta 1998, 1406(3):267-273.